204 related articles for article (PubMed ID: 16966733)
1. Prices and availability of biopharmaceuticals: an international comparison.
Danzon PM; Furukawa MF
Health Aff (Millwood); 2006; 25(5):1353-62. PubMed ID: 16966733
[TBL] [Abstract][Full Text] [Related]
2. International prices and availability of pharmaceuticals in 2005.
Danzon PM; Furukawa MF
Health Aff (Millwood); 2008; 27(1):221-33. PubMed ID: 18180499
[TBL] [Abstract][Full Text] [Related]
3. Explaining high health care spending in the United States: an international comparison of supply, utilization, prices, and quality.
Squires DA
Issue Brief (Commonw Fund); 2012 May; 10():1-14. PubMed ID: 22582452
[TBL] [Abstract][Full Text] [Related]
4. Explaining high health care spending in the United States: an international comparison of supply, utilization, prices, and quality.
Squires DA
Issue Brief (Commonw Fund); 2012 May; 10():1-14. PubMed ID: 22619775
[TBL] [Abstract][Full Text] [Related]
5. Spending on medicines in Israel in an international context.
Sax P
Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
[TBL] [Abstract][Full Text] [Related]
6. The economics of prescription drug prices, government intervention, and the importation of drugs from Canada.
Openshaw MS
Nurs Econ; 2005; 23(6):307-11, 279. PubMed ID: 16459902
[TBL] [Abstract][Full Text] [Related]
7. Higher US branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs.
Kanavos P; Ferrario A; Vandoros S; Anderson GF
Health Aff (Millwood); 2013 Apr; 32(4):753-61. PubMed ID: 23569056
[TBL] [Abstract][Full Text] [Related]
8. Canadian health expenditures: where do we really stand internationally?
Deber R; Swan B
CMAJ; 1999 Jun; 160(12):1730-4. PubMed ID: 10410638
[TBL] [Abstract][Full Text] [Related]
9. Approval of new biopharmaceuticals 1999-2006: comparison of the US, EU and Japan situations.
Tsuji K; Tsutani K
Eur J Pharm Biopharm; 2008 Mar; 68(3):496-502. PubMed ID: 17884403
[TBL] [Abstract][Full Text] [Related]
10. Health spending in OECD countries in 2004: an update.
Anderson GF; Frogner BK; Reinhardt UE
Health Aff (Millwood); 2007; 26(5):1481-9. PubMed ID: 17848460
[TBL] [Abstract][Full Text] [Related]
11. Paying for Prescription Drugs Around the World: Why Is the U.S. an Outlier?
Sarnak DO; Squires D; Kuzmak G; Bishop S
Issue Brief (Commonw Fund); 2017 Oct; 2017():1-14. PubMed ID: 28990747
[TBL] [Abstract][Full Text] [Related]
12. Differences in medical expenditure according to drug prices.
Ueshima H
Hypertens Res; 2006 May; 29(5):301-2. PubMed ID: 16832148
[No Abstract] [Full Text] [Related]
13. An analysis of expenditures on primary care prescription drugs in the United States versus ten comparable countries.
Morgan SG; Good CB; Leopold C; Kaltenboeck A; Bach PB; Wagner A
Health Policy; 2018 Sep; 122(9):1012-1017. PubMed ID: 30041827
[TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical price differences in the EU: investigation from cardiovascular disease drugs.
Timur A; Picone G
Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):251-6. PubMed ID: 19527097
[TBL] [Abstract][Full Text] [Related]
15. U.S. health care from a global perspective: spending, use of services, prices, and health in 13 countries.
Squires D; Anderson C
Issue Brief (Commonw Fund); 2015 Oct; 15():1-15. PubMed ID: 26591905
[TBL] [Abstract][Full Text] [Related]
16. Health care spending and use of information technology in OECD countries.
Anderson GF; Frogner BK; Johns RA; Reinhardt UE
Health Aff (Millwood); 2006; 25(3):819-31. PubMed ID: 16684749
[TBL] [Abstract][Full Text] [Related]
17. Market access for biopharmaceuticals: new challenges.
Simon F
Health Aff (Millwood); 2006; 25(5):1363-70. PubMed ID: 16966734
[TBL] [Abstract][Full Text] [Related]
18. European prices of newly launched reimbursable pharmaceuticals--a pilot study.
Martikainen J; Kivi I; Linnosmaa I
Health Policy; 2005 Nov; 74(3):235-46. PubMed ID: 16226136
[TBL] [Abstract][Full Text] [Related]
19. National healthcare spending and fiscal control: comparisons among 15 countries.
Eastaugh SR
Hosp Top; 2000; 78(4):9-13. PubMed ID: 11301901
[No Abstract] [Full Text] [Related]
20. Examining structural breaks and growth rates in international health expenditures.
Narayan PK
J Health Econ; 2006 Sep; 25(5):877-90. PubMed ID: 16426690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
